General Information of the Compound
| Compound ID |
CP0503370
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-chloro-N-{8-chloro-11-[4-(2,4-dimethyl-benzyl)-piperazin-1-yl]-dibenzo[b,e][1,4]diazepin-5-yl}-benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C33H31Cl2N5O
|
||||||||||||||||||
| Molecular Weight |
584.551
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc(CN2CCN(CC2)C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc23)c(C)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C33H31Cl2N5O/c1-22-11-12-24(23(2)19-22)21-38-15-17-39(18-16-38)32-27-8-4-6-10-30(27)40(31-14-13-25(34)20-29(31)36-32)37-33(41)26-7-3-5-9-28(26)35/h3-14,19-20H,15-18,21H2,1-2H3,(H,37,41)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SSGXOSRVRMKOMB-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT01005, D(2) dopamine receptor